| Gene symbol | S100A1 | Synonyms | S100, S100-alpha, S100A | Type of gene | protein-coding |
| Chromosome | 1 | Map location | 1q21.3 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | S100 calcium binding protein A1 | ||||
| Gene symbol | CXCL12 | Synonyms | IRH, PBSF, SCYB12, SDF1, TLSF, TPAR1 | Type of gene | protein-coding |
| Chromosome | 10 | Map location | 10q11.21 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | C-X-C motif chemokine ligand 12 | ||||
| Gene symbol | VEGFA | Synonyms | L-VEGF, MVCD1, VEGF, VPF | Type of gene | protein-coding |
| Chromosome | 6 | Map location | 6p21.1 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | vascular endothelial growth factor A | ||||
| GTO ID | GTC0415 |
| Trial ID | NCT03409627 |
| Disease | Heart Failure |
| Altered gene | SDF1|VEGFA|S100A1 |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | Gene transfer |
| Treatment | INXN-4001 |
| Phase | Phase1 |
| Recruitment status | Completed |
| Title | A Phase I, Open Label, Safety Study of INXN-4001 Delivered Via Retrograde Coronary Sinus Infusion in Patients With an Outpatient Left Ventricular Assist Device (LVAD) |
| Year | 2017 |
| Country | United States |
| Company sponsor | Triple-Gene, LLC |
| Other ID(s) | INXN-4001-001 |
| Vector information | |||
|
|||
| Cohort1: dose level 1 | |||||||||||||
|
|||||||||||||
| Cohort2: dose level 2 | |||||||||||||
|
|||||||||||||